Metabolic activation in drug allergies

Toxicology

Volumn 158, Issue 1-2, 2001, Pages 11-23

  Park, B K ^a   Naisbitt, D J ^a   Gordon, S F ^a   Kitteringham, N R ^a   Pirmohamed, M ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Adverse drug reaction; Allergy; Hypersensitivity

Indexed keywords

AMODIAQUINE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOZAPINE; PENICILLIN G; PHENOBARBITAL; PHENYTOIN; SULFAMETHOXAZOLE;

AGRANULOCYTOSIS; ANAPHYLAXIS; ANTIGENICITY; ARTICLE; BLOOD DYSCRASIA; DRUG ACTIVATION; DRUG BINDING; DRUG HYPERSENSITIVITY; DRUG METABOLISM; HUMAN; IMMUNOGENICITY; LIVER TOXICITY; PRIORITY JOURNAL;

ANIMALS; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; HAPTENS; HEMATOLOGIC DISEASES; HUMANS; MODELS, ANIMAL; PHARMACEUTICAL PREPARATIONS; TOXICITY TESTS;

EID: 0035793373     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-483X(00)00397-8     Document Type: Article

References (72)

1. New aspects on antigens in penicillin allergy
2. Dendritic cells and the control of immunity
3. Penicillin allergy: The formation of the penicilloyl determinant
4. Drug hypersensitivity reactions and immunodeficiency virus
5. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human cytochrome P450 that hydroxylates the drug
6. Sensitivity to a metabolite of diclofenac as a cause of acute immune hemolytic anemia
7. Heterogeneous T-cell responses to beta-lactam-modified self structures are observed in penicillin-allergic individuals
8. Cytochrome P450 CYP1B1 determines susceptibility to 7,12-dimethylbenz[a]antracene-induced lymphomas
9. Immunohistological assessment of cutaneous drug hypersensitivity in patients with HIV infection
10. Pathogenesis and management of HIV-associated drug hypersensitivity
11. Drug-Protein Conjugates XVII. The effect of storage on the disposition and immunogenicity of benzylpenicillin in the rat
12. Detection of antidrug IgG antibodies in patients with adverse drug reactions to amodiaquine
13. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs
14. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity
15. N4-hydroxylation of sulfamethoxazole by cytochrome P450 of the cytochrome P4502C subfamily and reduction of sulfamethoxazole hydroxylamine in human and drat hepatic microsomes
16. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection
17. Some immunological properties of penicillenic acid. An antigenic determinant derived from penicillin
18. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
19. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine
20. The effect of fluconazole and ketoconazole on the metabolism of sulphamethoxazole
21. The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat
22. The association of atopy with a gain-of-function mutation in the alpha-subunit of the interleukin-4 receptor
23. + dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes
24. New active substances authorized in the United Kingdom between 1972 and 1994
25. Detection of 2-hydroxyiminostilbene in urine of patients taking carbamazepine and its oxidation to a reactive iminoquinone intermediate
26. + T cell-mediated delayed hypersensitivity: Implications for allergies, asthma and autoimmunity
27. + T cell-mediated contact hypersensitivity
28. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct
29. Fixation of penicilloyl groups to albumin and appearance of anti-penicilloyl antibodies in penicillin-treated patients
30. Studies on the sensitization of animals with simple chemical compounds
31. Incidence of adverse drug reactions in hospitalized patients
32. Role of CYP2E1 in the hepatotoxicity of acetaminophen
33. Non-mono-oxygenase cytochromes P450 as potential autoantigens in anticonvulsant hypersensitivity reactions
34. Studies on the mechanism of the formation of the penicillin antigen
35. Immunochemical mechanisms of penicillin induced Coombs positivity and hemolytic anemia in man
36. Formation of haemoglobin and albumin adducts of benzene oxide in mouse, rat and human blood
37. Bioactivation of carbamazepine in the rat in-vivo-evidence for the formation of reactive arene oxide(s)
38. Tolerance, danger, and the extended family
39. An innate sense of danger
40. + T cells in individuals allergic to sulphonamides, phenytoin and carbamazepine
41. +/CD19- human bone marrow progenitor cells: Potential relevance to remoxipride-induced aplastic anemia
42. Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substituted serum proteins
43. Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy
44. T-cell subsets in drug-induced toxic epidermal necrolysis. Possible pathogenic mechanism induced by CD8-positive T cells
45. Synthesis and reactions of nitroso sulfamethoxazole with biological nucleophiles-implications for immune-mediated toxicity
46. Cellular disposition of suphamethoxazole and its metabolites; implications for hypersensitivity
47. Drug-protein conjugates XI. Disposition and immunogenicity of dinitrofluorobenzene, a model compound for the investigation of drugs as haptens
48. The role of cytochrome P450 enzymes in hepatic and extrahepatic human drug toxicity
49. Role of drug disposition in drug hypersensitivity: A chemical, molecular and clinical perspective
50. Coombs-positive hemolytic anemia caused by penicillin administration
51. Role of T cells in drug allergies
52. Drug reactions in HIV infected patients
53. Carbamazepine hypersensitivity: Assessment of clinical and in vitro chemical cross-reactivity with phenytoin and oxcarbazepine
54. Adverse Drug reactions: Current status
55. Immunochemical detection of liver protein adducts of the nonsteroidal antiinflammatory drug diclofenac
56. Severe adverse cutaneous reactions to drugs
57. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis
58. Lamotrigine-induced Stevens-Johnson syndrome: Demonstration of specific lymphocyte reactivity in vitro
59. Direct MHC-dependent presentation of the drug sulfamethoxazole to human alpha beta T cell clones
60. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction
61. Anticonvulsant hypersensitivity syndrome: In vitro risk assessment
62. Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as detoxification mechanism?
63. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions
64. New concepts in immunology relevant to idiosyncratic drug toxicity: The 'danger hypothesis' and innate immunity
65. Reduction of benzene metabolism and toxicity in mice that lack CYP2E1 expression
66. Immunopathology of toxic epidermal necrolysis
67. Lamotrigine and toxic epidermal necrolysis
68. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: Possible role in agranulocytosis
69. Chronic physical-activity alters hepatobiliary excretory function in rats
70. In vitro lymphocyte proliferation by carbamazepine, carbamazepine-10,11-epoxide, and oxcarbazepine in the diagnosis of drug-induced hypersensitivity
71. Involvement of T cells in drug-induced allergies
72. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human Âβ T lymphocytes